Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
5
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
US Stock MarketDetailed Quotes
Zentalis Pharmaceuticals (ZNTL)
- 3.660
- -0.210-5.43%
Close Jun 5 16:00 ET
- 3.603
- -0.057-1.55%
Post 19:40 ET
260.54MMarket Cap-2.10P/E (TTM)
3.850High3.420Low1.01MVolume3.850Open3.870Prev Close3.67MTurnover2.07%Turnover RatioLossP/E (Static)71.19MShares6.95052wk High1.43P/B179.22MFloat Cap1.13052wk Low--Dividend TTM48.97MShs Float87.190Historical High--Div Yield TTM11.11%Range %1.010Historical Low3.620Avg Price1Lot Size
Zentalis Pharmaceuticals (ZNTL) Key Financial Indicators
ZNTL Earnings per Share (EPS)
According to the latest financial report of Zentalis Pharmaceuticals, the latest earnings per share (TTM) for the company is -0.50. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
ZNTL Free Cash Flow (FCF)
Interested in knowing about Zentalis Pharmaceuticals's free cash flow? The latest report shows it as -32.99M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
ZNTL Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Zentalis Pharmaceuticals shows that the company's current ratio is 6.19, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
ZNTL Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Zentalis Pharmaceuticals, the quick ratio is 6.01, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ZNTL Return on Equity (ROE)
Want to learn more about the financial health of Zentalis Pharmaceuticals? The latest ROE figure is -17.73%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ZNTL Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Zentalis Pharmaceuticals, the total asset return on investment (ROA) is -13.04%.
Currency: USD
Quarterly
Loading...
ZNTL Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Zentalis Pharmaceuticals's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
ZNTL Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Zentalis Pharmaceuticals, the net profit margin is -176.71%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On June 3, Eastern Time, the U.S. House of Representatives passed a resolution limiting Trump's authority to use military force against Iran
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm